Home > Press > Multifunctional Polymer Nanoparticles Pass Critical In Vivo Test
Abstract:
In an effort to overcome the drug resistance that often occurs in cancer, a team of investigators has developed a nanoparticle made of a blend of polymers that first releases a powerful anticancer drug and then delivers an agent that tricks a drug-resistant cell into committing suicide. Now, tests in mice with human breast cancer have shown that these blended nanoparticles are effective in maintaining high levels of both drugs in the vicinity of tumors.
Mansoor Amiji, Ph.D., Principal Investigator, Nanotherapeutic Strategy for Multidrug-Resistant Tumors Platform Partnership at Northeastern University, led the research team that reported on this study in the journal Molecular Pharmaceutics. This platform partnership is part of the NCI Alliance for Nanotechnology in Cancer, a comprehensive initiative designed to accelerate the application of nanotechnology to the prevention, diagnosis, and treatment of cancer.
In a previous study, Dr. Amiji and his collaborators showed that the combination of the anticancer drug paclitaxel and a molecule known as ceramide was able to kill drug-resistant breast cancer cells growing in culture. Ceramide is a naturally occurring compound that cells produce to trigger apoptosis (programmed cell death) when the cells suffer irreversible damage, such as when they are exposed to an anticancer drug. Tumor cells that have developed drug resistance are able to destroy ceramide before it triggers the apoptosis pathway.
In the current study, these two drugs were encapsulated in a single nanoparticle made of two polymers. One polymer, known as poly(beta-amino ester) (PbAE), dissolves rapidly in the acidic environment inside tumor cells, and the researchers used that polymer to encapsulate paclitaxel. The second polymer, poly(d,l-lactide-co-glycolide) (PLGA), dissolves far more slowly under the same conditions, affording a means of encapsulating ceramide for release after a time delay, when a drug-resistant cell will be trying to avoid apoptosis.
The researchers injected these nanoparticles into mice with human breast tumors. They then measured drug concentrations both in blood and in the vicinity of the tumors. The results showed that this blended nanoparticle was able to sustain high levels of the drugs in the mice and that, as a result, the drugs accumulated in the tumors. This study was not intended to determine whether the drugs had the desired therapeutic effect; those data will come from studies that are now under way.
####
About National Cancer Institute
To help meet the goal of reducing the burden of cancer, the National Cancer Institute (NCI), part of the National Institutes of Health, is engaged in efforts to harness the power of nanotechnology to radically change the way we diagnose, treat and prevent cancer.
The NCI Alliance for Nanotechnology in Cancer is a comprehensive, systematized initiative encompassing the public and private sectors, designed to accelerate the application of the best capabilities of nanotechnology to cancer.
Currently, scientists are limited in their ability to turn promising molecular discoveries into benefits for cancer patients. Nanotechnology can provide the technical power and tools that will enable those developing new diagnostics, therapeutics, and preventives to keep pace with today’s explosion in knowledge.
For more information, please click here
Contacts:
National Cancer Institute
Office of Technology & Industrial Relations
ATTN: NCI Alliance for Nanotechnology in Cancer
Building 31, Room 10A49
31 Center Drive , MSC 2580
Bethesda , MD 20892-2580
Copyright © National Cancer Institute
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related Links |
Related News Press |
News and information
New method in the fight against forever chemicals September 13th, 2024
Energy transmission in quantum field theory requires information September 13th, 2024
Breakthrough in proton barrier films using pore-free graphene oxide: Kumamoto University researchers achieve new milestone in advanced coating technologies September 13th, 2024
Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024
Nanomedicine
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
The mechanism of a novel circular RNA circZFR that promotes colorectal cancer progression July 5th, 2024
Discoveries
Energy transmission in quantum field theory requires information September 13th, 2024
Breakthrough in proton barrier films using pore-free graphene oxide: Kumamoto University researchers achieve new milestone in advanced coating technologies September 13th, 2024
Quantum researchers cause controlled ‘wobble’ in the nucleus of a single atom September 13th, 2024
Announcements
New discovery aims to improve the design of microelectronic devices September 13th, 2024
New method in the fight against forever chemicals September 13th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||